Featured Research

from universities, journals, and other organizations

Pitchers: Elbow position not a predictor of injury

Date:
February 11, 2012
Source:
American Orthopaedic Society for Sports Medicine
Summary:
Elbow position alone appeared to not affect injury rates and performance in college-level, male pitchers say researchers.

Elbow position alone appeared to not affect injury rates and performance in college-level, male pitchers say researchers presenting at the American Orthopaedic Society for Sports Medicine's Specialty Day in San Francisco, CA.

"The elbow's position in relation to an injury and enhanced performance in baseball pitchers is highly dependent upon the trunk's position," said lead researcher, Carl W. Nissen, MD of Elite Sports Medicine and Connecticut Children's Medical Center in Farmington, CT. "Our research showed that the pitching motion is complex and a direct relationship between true elbow position and how much stress is placed on a joint does not appear to exist."

The researchers studied 55 collegiate-level, male pitchers who pitched a fastball towards a target 60'6" away. Kinematic data was collected using a Vicon 512 motion capture system, and kinetic data was calculated using custom Matlab programming based on inverse dynamic techniques.

Visual elbow drag had a positive association with ball velocity (p=0.046). Regression analysis showed that for every 10cm of visual elbow drag ball velocity was decreased by 1.3m/s. "The results of this study suggest that an improperly positioned elbow (visual or true) is not a factor in increasing injury rates as neither elbow drop nor drag correlated with elbow stress. Elbow drag, however, did correlate with decreased ball velocity demonstrating that elbow position is important for pitcher performance," said Nissen.


Story Source:

The above story is based on materials provided by American Orthopaedic Society for Sports Medicine. Note: Materials may be edited for content and length.


Cite This Page:

American Orthopaedic Society for Sports Medicine. "Pitchers: Elbow position not a predictor of injury." ScienceDaily. ScienceDaily, 11 February 2012. <www.sciencedaily.com/releases/2012/02/120211095255.htm>.
American Orthopaedic Society for Sports Medicine. (2012, February 11). Pitchers: Elbow position not a predictor of injury. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/02/120211095255.htm
American Orthopaedic Society for Sports Medicine. "Pitchers: Elbow position not a predictor of injury." ScienceDaily. www.sciencedaily.com/releases/2012/02/120211095255.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins